Breath analysis for disease

Breathomix is developing the BreathBase® Solution for the early detection of cancer, inflammatory and infectious disease.

Our Mission

Making breath analysis as routine in clinical practice as blood testing

Our Vision

Setting the standard in breath analysis for early detection and precision medicine—accessible from hospitals to homes

The BreathBase® Solution

 

SpiroNose of Breathomix for analysis of exhaled breath

SpiroNose®

For reliable and reproducible measurements of the complete mixture of volatile organic compounds (VOCs) in exhaled breath.

BreathBase Solution; BreathBase Platform; Exhaled breath analysis; eNose

BreathBase® Platform

From high-quality breath measurements to the generation and validation of diagnostic models and composite biomarkers.

BreathBase; Breath Profile database; Breath Analysis

BreathBase® Data

The world’s largest and dynamic database, filled with exhaled breath profiles and clinical data of patients with a known diagnosis.

About Breathomix

Breathomix is a leader in eNose technology and breath analysis, creating non-invasive diagnostic solutions to advance early disease detection and precision medicine across fields such as cancer, inflammatory, and infectious diseases. Our BreathBase® Solution enables reliable, reproducible analysis of the full spectrum of volatile organic compounds (VOCs) in exhaled breath, driving high-quality research and diagnostics. From hospitals to home care, Breathomix is pioneering accessible breath diagnostics to transform patient care through innovative breath analysis technology.

 

Discover the latest clinical studies and publications:

Our technology partners: